The layer 1 blockchain token advanced on moderately elevated volume but underperformed key benchmarks, raising sustainability questions.Markets, AI Market InsightsRead More
You might also be interested in reading SpringWorks Therapeutics may be worth around $77 a share in a takeover – analyst.